Podcasts

In our exclusive interview, Dr. Tripathy discusses the state of treatment in metastatic HER2-positive breast cancer, current sequencing strategies, and targeted agents under evaluation in this setting.

Tripathy Spotlights the State of Treatment in Metastatic HER2+ Breast Cancer

Videos

Prithviraj Bose, MD, discusses novel agents under investigation in essential thrombocythemia.

Dr. Bose on Novel Agents Under Investigation in Essential Thrombocythemia

Naveen Pemmaraju, MD, discusses the need to develop novel therapies in myeloproliferative neoplasms.  



Dr. Pemmaraju the Need to Develop Novel Therapies in MPNs 

Shannon N. Westin, MD, MPH, discusses remaining challenges in endometrial cancer.  



Dr. Westin on Remaining Challenges in Endometrial Cancer 

Van K. Morris, MD, discusses the design of the prospective phase 2/3 NRG-GI005 (COBRA) trial evaluating circulating tumor DNA as a predictive biomarker for adjuvant chemotherapy in patients with colon cancer.  



Dr. Morris on the Design of the COBRA Trial in Stage II Colon Cancer 

Vivek Subbiah, MD, discusses the clinical implications of the approval of pralsetinib in patients with RET fusion–positive non–small cell lung cancer.   



MD Anderson

Latest from MD Anderson

New content coming soon, please check back later.